Position in BMY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$325,437
+$89,249 QoQ
Shares Held
5,648
+7.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,825
of 2,506 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compass Wealth Management LLC holds $18,364,693 across 8 Drug Manufacturers - General names. BMY ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,093 | $7,308,127 | |
| 2 | ABBV |
AbbVie Inc.
|
25,828 | $6,499,357 | |
| 3 | NVS |
Novartis AG
|
12,747 | $1,997,709 | |
| 4 | JNJ |
Johnson & Johnson
|
3,985 | $1,012,070 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,487 | $833,579 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
5,648 | $325,437 | |
| 7 | AMGN |
Amgen Inc
|
775 | $280,643 | |
| 8 | GRFS |
Grifols SA
|
15,222 | $107,771 |
All Filings in BMY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $325,437 | 5,648 | Shares | Sole | 2026-08-10 | |
| 2025-09-30 | $236,188 | 5,237 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $225,541 | 3,698 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $124,318 | 2,198 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $113,724 | 2,198 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $242,119 | 5,830 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $415,510 | 7,662 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $673,289 | 13,122 | Shares | Sole | 2024-01-04 | |
| 2023-09-30 | $1,396,036 | 24,053 | Shares | Sole | 2023-10-25 | |
| 2023-03-31 | $1,734,136 | 25,020 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,865,951 | 25,934 | Shares | Sole | 2023-02-17 | |
| No filing history on record for this holder in this stock. | ||||||